$BHC
Bausch Health Companies Inc.

2015 Q2 Form 10-Q Financial Statement

#000088559015000064 Filed on July 28, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2 2014 Q1
Revenue $2.733B $2.041B $1.886B
YoY Change 33.9% 86.28% 76.54%
Cost Of Revenue $669.9M $569.6M $504.1M
YoY Change 17.61% 101.13% 76.94%
Gross Profit $2.063B $1.472B $1.382B
YoY Change 40.2% 81.11% 76.4%
Gross Profit Margin 75.49% 72.09% 73.27%
Selling, General & Admin $685.5M $515.7M $482.0M
YoY Change 32.93% 100.43% 99.26%
% of Gross Profit 33.23% 35.05% 34.87%
Research & Development $81.10M $66.50M $61.30M
YoY Change 21.95% 171.43% 157.56%
% of Gross Profit 3.93% 4.52% 4.44%
Depreciation & Amortization $635.0M $407.7M $401.1M
YoY Change 55.75% 28.25% 17.49%
% of Gross Profit 30.78% 27.71% 29.02%
Operating Expenses $766.6M $582.2M $543.3M
YoY Change 31.67% 106.6% 104.48%
Operating Profit $342.0M $355.1M $356.6M
YoY Change -3.69% 150.95% 204.79%
Interest Expense -$406.2M -$234.1M -$258.1M
YoY Change 73.52% 28.7% 71.61%
% of Operating Profit -118.77% -65.93% -72.38%
Other Income/Expense, Net
YoY Change
Pretax Income -$64.70M $121.0M $4.800M
YoY Change -153.47% -399.5% -108.76%
Income Tax -$13.10M -$1.000M $25.10M
% Of Pretax Income -0.83% 522.92%
Net Earnings -$51.60M $122.0M -$20.30M
YoY Change -142.3% 1029.63% -26.18%
Net Earnings / Revenue -1.89% 5.98% -1.08%
Basic Earnings Per Share -$0.15 $0.38 -$0.07
Diluted Earnings Per Share -$0.15 $0.37 -$0.07
COMMON SHARES
Basic Shares Outstanding 344.4M shares 335.3M shares 334.9M shares
Diluted Shares Outstanding 344.4M shares 341.3M shares 334.9M shares

Balance Sheet

Concept 2015 Q2 2014 Q2 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $958.0M $531.0M $576.0M
YoY Change 80.41% -79.09% 39.13%
Cash & Equivalents $958.0M $531.2M $576.3M
Short-Term Investments
Other Short-Term Assets $1.786B $1.920B $714.0M
YoY Change -6.98% 421.74% 81.68%
Inventory $1.230B $942.5M $953.4M
Prepaid Expenses
Receivables $2.371B $1.771B $1.706B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.345B $5.164B $3.950B
YoY Change 22.88% 13.94% 66.66%
LONG-TERM ASSETS
Property, Plant & Equipment $1.360B $1.320B $1.215B
YoY Change 3.05% 199.23% 168.23%
Goodwill $17.23B $9.436B $9.916B
YoY Change 82.63% 78.79% 91.97%
Intangibles $23.15B $11.75B $12.70B
YoY Change 97.0% 26.5% 37.65%
Long-Term Investments
YoY Change
Other Assets $167.0M $206.3M $185.9M
YoY Change -19.05% 3.44% 3.04%
Total Long-Term Assets $42.00B $22.73B $24.04B
YoY Change 84.75% 49.06% 59.03%
TOTAL ASSETS
Total Short-Term Assets $6.345B $5.164B $3.950B
Total Long-Term Assets $42.00B $22.73B $24.04B
Total Assets $48.34B $27.90B $27.99B
YoY Change 73.3% 41.01% 60.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $415.8M $327.7M $392.3M
YoY Change 26.88% 15.17% 114.35%
Accrued Expenses $3.055B $1.775B $1.802B
YoY Change 72.11% 71.49% 68.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $590.9M $266.7M $238.9M
YoY Change 121.56% -23.11% -17.53%
Total Short-Term Liabilities $4.291B $2.496B $2.563B
YoY Change 71.89% 41.69% 55.7%
LONG-TERM LIABILITIES
Long-Term Debt $30.29B $17.06B $17.15B
YoY Change 77.56% 63.29% 66.04%
Other Long-Term Liabilities $208.8M $215.0M $230.0M
YoY Change -2.88% 32.95% 37.66%
Total Long-Term Liabilities $30.50B $17.27B $17.38B
YoY Change 76.56% 62.82% 65.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.291B $2.496B $2.563B
Total Long-Term Liabilities $30.50B $17.27B $17.38B
Total Liabilities $41.78B $22.53B $22.79B
YoY Change 85.48% 60.01% 63.93%
SHAREHOLDERS EQUITY
Retained Earnings -$2.388B -$3.175B -$3.301B
YoY Change -24.8% 30.72% 36.2%
Common Stock $10.11B $8.538B $8.531B
YoY Change 18.47% 0.74% 37.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.435B $5.258B $5.090B
YoY Change
Total Liabilities & Shareholders Equity $48.34B $27.90B $27.99B
YoY Change 73.3% 41.01% 60.06%

Cashflow Statement

Concept 2015 Q2 2014 Q2 2014 Q1
OPERATING ACTIVITIES
Net Income -$51.60M $122.0M -$20.30M
YoY Change -142.3% 1029.63% -26.18%
Depreciation, Depletion And Amortization $635.0M $407.7M $401.1M
YoY Change 55.75% 28.25% 17.49%
Cash From Operating Activities $418.0M $376.0M $484.3M
YoY Change 11.17% 23.24% 89.7%
INVESTING ACTIVITIES
Capital Expenditures $46.80M $113.5M $58.10M
YoY Change -58.77% 786.72% 315.0%
Acquisitions $13.09B $68.00M $306.3M
YoY Change 19151.32% -86.75% 28.91%
Other Investing Activities $500.0K -$1.400M -$1.400M
YoY Change -135.71% -99.71% -99.36%
Cash From Investing Activities -$2.645B -$266.4M -$384.1M
YoY Change 892.94% -49.9% 63.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $50.00M $0.00 $0.00
YoY Change -100.0% -100.0%
Debt Paid & Issued, Net $247.9M $120.3M $433.9M
YoY Change 106.07% -31.14% 0.91%
Cash From Financing Activities $1.325B -$156.6M -$122.7M
YoY Change -946.3% -106.65% -76.22%
NET CHANGE
Cash From Operating Activities $418.0M $376.0M $484.3M
Cash From Investing Activities -$2.645B -$266.4M -$384.1M
Cash From Financing Activities $1.325B -$156.6M -$122.7M
Net Change In Cash -$901.9M -$47.00M -$22.50M
YoY Change 1818.94% -102.21% -95.46%
FREE CASH FLOW
Cash From Operating Activities $418.0M $376.0M $484.3M
Capital Expenditures $46.80M $113.5M $58.10M
Free Cash Flow $371.2M $262.5M $426.2M
YoY Change 41.41% -10.2% 76.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000885590
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
342788885 shares
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
415800000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2179400000 USD
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Valeant Pharmaceuticals International, Inc.
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
398000000 USD
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3054700000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-132800000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-104700000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-915900000 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1291500000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
243900000 USD
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
234000000 USD
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-36500000 USD
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-61500000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40400000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
60900000 USD
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1200000 USD
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
25600000 USD
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15600000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40400000 USD
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25900000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
60900000 USD
CY2014Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
11300000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
23500000 USD
CY2015Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
92700000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
103200000 USD
CY2014Q4 us-gaap Assets
Assets
26327300000 USD
CY2015Q2 us-gaap Assets
Assets
48343200000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
4193100000 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
6345200000 USD
CY2014Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.15
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-1.03
CY2015Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.07
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.96
CY2014Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.15
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-1.03
CY2015Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.07
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.96
CY2014Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-51700000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-353800000 USD
CY2015Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-24900000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-329600000 USD
CY2014Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2595700000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
5055100000 USD
CY2015Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2732400000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
4883700000 USD
CY2014Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
600000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2100000 USD
CY2015Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9500000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
19300000 USD
CY2014Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-1900000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-10800000 USD
CY2015Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-11700000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-18800000 USD
CY2014Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
141800000 USD
CY2015Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
191400000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
600300000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
576300000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
531200000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
322600000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1864400000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
958000000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2015Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
334402964 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
342769031 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
334402964 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
342769031 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
8349200000 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
9880800000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
161100000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
131300000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16900000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-354900000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-4700000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-3200000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1200000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1800000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
156400000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
128100000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-15700000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-353100000 USD
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
569600000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1073700000 USD
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
669900000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1230300000 USD
CY2014Q2 us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
16000000 USD
us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
30300000 USD
CY2015Q2 us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
15200000 USD
us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
29500000 USD
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
1686000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
3215600000 USD
CY2015Q2 us-gaap Costs And Expenses
CostsAndExpenses
2390900000 USD
us-gaap Costs And Expenses
CostsAndExpenses
4038400000 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
193300000 USD
CY2015Q2 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
711400000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
54000000 USD
CY2015Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
88300000 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
859000000 USD
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1030000000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
10700000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
38200000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2227500000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
6152800000 USD
CY2014Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
407700000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
808800000 USD
CY2015Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
635000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1042000000 USD
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2014Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
1900000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
400000 USD
CY2015Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
3000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-12100000 USD
CY2014Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1200000 USD
CY2015Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
7700000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
25600000 USD
CY2014Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1200000 USD
CY2015Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
7700000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
25600000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5140600000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6020100000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2218000000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2223700000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2361500000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2493700000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2520300000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14408900000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
26594100000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9268300000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20574000000 USD
CY2014Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3400000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10000000 USD
CY2015Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5600000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-65500000 USD
CY2014Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
5300000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-7300000 USD
CY2015Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
10300000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-65600000 USD
CY2014Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
2500000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
2500000 USD
CY2015Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
CY2014Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1500000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
47300000 USD
CY2015Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-4800000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-6300000 USD
CY2014Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-93700000 USD
CY2015Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-20000000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
9346400000 USD
CY2015Q2 us-gaap Goodwill
Goodwill
17233100000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
8026900000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
50200000 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-190400000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
121000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
125800000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-64700000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
90700000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24100000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
67800000 USD
CY2014Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-124900000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-72300000 USD
CY2015Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
111200000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
52500000 USD
CY2014Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
53700000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
83800000 USD
CY2015Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
241800000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
308800000 USD
CY2014Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12100000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
81300000 USD
CY2015Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
48300000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
86800000 USD
CY2014Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-24800000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-29000000 USD
CY2015Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
118400000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
163500000 USD
CY2014Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
CY2015Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-10343900000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
5200000 USD
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6300000 shares
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6600000 shares
vrx Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax
2700000 USD
CY2014Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
16396500000 USD
CY2015Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
29169800000 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11255900000 USD
CY2015Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23149700000 USD
CY2014Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
241200000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
487700000 USD
CY2015Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
412700000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
710500000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
665300000 USD
CY2015Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
843000000 USD
CY2014Q4 us-gaap Inventory Gross
InventoryGross
950600000 USD
CY2015Q2 us-gaap Inventory Gross
InventoryGross
1229500000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
950600000 USD
CY2015Q2 us-gaap Inventory Net
InventoryNet
1229500000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
191100000 USD
CY2015Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
260600000 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
94200000 USD
CY2015Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
125900000 USD
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1200000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
3000000 USD
CY2015Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
900000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1800000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
20892800000 USD
CY2015Q2 us-gaap Liabilities
Liabilities
41784800000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26327300000 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48343200000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2730800000 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4291000000 USD
CY2014Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
102600000 USD
CY2015Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
101200000 USD
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
15228900000 USD
CY2015Q2 us-gaap Long Term Debt
LongTermDebt
30881100000 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
900000 USD
CY2015Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
590900000 USD
CY2014Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
15780000000 USD
CY2015Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
31850000000 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15228000000 USD
CY2015Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
30290200000 USD
CY2014Q4 us-gaap Minority Interest
MinorityInterest
122300000 USD
CY2015Q2 us-gaap Minority Interest
MinorityInterest
123000000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1100000 USD
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
3300000 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-45100000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-69100000 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-906400000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
635400000 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-156600000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-279300000 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1325300000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13631600000 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-266400000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-650500000 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2645200000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13885700000 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
376000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
860300000 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
410500000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
901600000 USD
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3800000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1500000 USD
CY2015Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1400000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2200000 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
125800000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
103200000 USD
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-53000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20700000 USD
CY2014Q2 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
4000000 USD
CY2015Q2 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
3123100000 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
3123100000 USD
CY2015Q2 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
100 country
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
355100000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
711700000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
341500000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
884900000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
167400000 USD
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
167000000 USD
CY2014Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
600000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
1200000 USD
CY2015Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
500000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
900000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
8100000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-374700000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13800000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6400000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
36400000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-375100000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
26400000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-376000000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
34400000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
26400000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
35900000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-376000000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
1200000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
900000 USD
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
18500000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
18500000 USD
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
197100000 USD
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
208800000 USD
CY2014Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3700000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6100000 USD
CY2015Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2700000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
9900000 USD
CY2014Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
400000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
43700000 USD
CY2015Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-176900000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-183000000 USD
CY2014Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
47000000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
82100000 USD
CY2015Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
37400000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
81400000 USD
CY2014Q2 us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
0 USD
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
0 USD
CY2015Q2 us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
26300000 USD
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
26300000 USD
CY2014Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
900000 USD
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
1000000 USD
CY2015Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
2900000 USD
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
5900000 USD
CY2014Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1400000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2800000 USD
CY2015Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
500000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2014Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2015Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000000 USD
CY2014Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
200000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8600000 USD
CY2015Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
75100000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
101700000 USD
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
18000000 USD
CY2014Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8800000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
36500000 USD
CY2015Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
45600000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
61500000 USD
CY2014Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
68000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
374300000 USD
CY2015Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
13090900000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
13885900000 USD
CY2014Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
75900000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
75900000 USD
CY2015Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
CY2014Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
10400000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
31500000 USD
CY2015Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9200000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
58000000 USD
CY2014Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
113500000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
171600000 USD
CY2015Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46800000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
112600000 USD
CY2014Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
239800000 USD
CY2015Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
226400000 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
650800000 USD
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1075300000 USD
CY2014Q2 us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
0 USD
us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
0 USD
CY2015Q2 us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
184600000 USD
us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
184600000 USD
CY2014Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2015Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1433700000 USD
CY2014Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
49300000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
408400000 USD
CY2015Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4921400000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
16925800000 USD
CY2014Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7700000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-14500000 USD
CY2015Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1300000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-400000 USD
CY2014Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
CY2015Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
17700000 USD
CY2014Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3600000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7100000 USD
CY2015Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7600000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
22100000 USD
CY2014Q2 us-gaap Profit Loss
ProfitLoss
122000000 USD
us-gaap Profit Loss
ProfitLoss
101700000 USD
CY2015Q2 us-gaap Profit Loss
ProfitLoss
-51600000 USD
us-gaap Profit Loss
ProfitLoss
22900000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1310500000 USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1359900000 USD
CY2014Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
2075800000 USD
CY2015Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
2371000000 USD
CY2014Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
120300000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
554200000 USD
CY2015Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
247900000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1358200000 USD
CY2014Q2 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
CY2015Q2 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
3122800000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
3122800000 USD
CY2014Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
66500000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
127800000 USD
CY2015Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
81100000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
136900000 USD
CY2014Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
400000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
400000 USD
CY2015Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
12300000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
12300000 USD
CY2014Q2 us-gaap Restructuring Charges
RestructuringCharges
142100000 USD
us-gaap Restructuring Charges
RestructuringCharges
275700000 USD
CY2015Q2 us-gaap Restructuring Charges
RestructuringCharges
143400000 USD
us-gaap Restructuring Charges
RestructuringCharges
198400000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2365000000 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2387900000 USD
CY2014Q2 us-gaap Revenues
Revenues
2041100000 USD
us-gaap Revenues
Revenues
3927300000 USD
CY2015Q2 us-gaap Revenues
Revenues
2732400000 USD
us-gaap Revenues
Revenues
4923300000 USD
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1994100000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3845200000 USD
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2695000000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4841900000 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
515700000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
997700000 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
685500000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1259300000 USD
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
15600000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
40400000 USD
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
25900000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
60900000 USD
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7286432 shares
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1450000000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1481000000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7200000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
22100000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
50000000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
5312200000 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
6435400000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5233300000 USD
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5367300000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5434500000 USD
CY2015Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6558400000 USD
CY2015Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
7000000 USD
CY2015Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
40000000 USD
CY2015Q2 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
33000000 USD
CY2015Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
102000000 USD
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
341300000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
341400000 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
344400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
347100000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335100000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
344400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
340500000 shares
CY2014Q2 vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
4300000 USD
vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
9500000 USD
CY2015Q2 vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
46000000 USD
vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
70500000 USD
CY2015Q2 vrx Allocated Sharebase Compensation Expense Reversal
AllocatedSharebaseCompensationExpenseReversal
6000000 USD
CY2014Q2 vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
16000000 USD
vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
35600000 USD
CY2015Q2 vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
14600000 USD
vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
26800000 USD
CY2014Q2 vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
365600000 USD
vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
720800000 USD
CY2015Q2 vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
585400000 USD
vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
950600000 USD
CY2014Q2 vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
27400000 USD
vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
49100000 USD
CY2015Q2 vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
387700000 USD
vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
674600000 USD
CY2014Q2 vrx Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold
BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold
3000000 USD
vrx Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold
BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold
8000000 USD
CY2015Q2 vrx Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold
BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold
45000000 USD
vrx Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold
BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold
69000000 USD
CY2014Q2 vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
1900000 USD
vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
10800000 USD
CY2015Q2 vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
11700000 USD
vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
18800000 USD
CY2014Q4 vrx Business Combination Contingent Consideration Noncurrent Liability
BusinessCombinationContingentConsiderationNoncurrentLiability
167000000 USD
CY2015Q2 vrx Business Combination Contingent Consideration Noncurrent Liability
BusinessCombinationContingentConsiderationNoncurrentLiability
514400000 USD
CY2014Q2 vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-21400000 USD
vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-11400000 USD
CY2015Q2 vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-50100000 USD
vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
12400000 USD
vrx Fair Value Assets Level1to Level2 Transfers Value
FairValueAssetsLevel1toLevel2TransfersValue
0 USD
vrx Highly Liquid Investments Maturity Period
HighlyLiquidInvestmentsMaturityPeriod
P3M
vrx Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax
18500000 USD
CY2014Q2 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax
2700000 USD
CY2015Q2 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax
0 USD
vrx Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2014Q2 vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
7500000 USD
vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
8200000 USD
CY2015Q2 vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
9900000 USD
vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
12100000 USD
CY2014Q2 vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
72500000 USD
vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
82200000 USD
CY2015Q2 vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
68700000 USD
vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
81000000 USD
CY2015Q2 vrx Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
350900000 shares
CY2014Q2 vrx Research And Development In Process And Other Charges
ResearchAndDevelopmentInProcessAndOtherCharges
8400000 USD
vrx Research And Development In Process And Other Charges
ResearchAndDevelopmentInProcessAndOtherCharges
20400000 USD
CY2015Q2 vrx Research And Development In Process And Other Charges
ResearchAndDevelopmentInProcessAndOtherCharges
12300000 USD
vrx Research And Development In Process And Other Charges
ResearchAndDevelopmentInProcessAndOtherCharges
12300000 USD
CY2015Q1 vrx Saleof Stock Public Offering Price Per Share
SaleofStockPublicOfferingPricePerShare
199.00
CY2015Q1 vrx Sharebased Compensation Arrangementby Sharebased Payment Award Additional Purchase Optionasa Percentageof Shares Issuedin Ipo Maximum
SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalPurchaseOptionasaPercentageofSharesIssuedinIPOMaximum
0.15
vrx Stock Issued During Period Value Equity Settlement And Reclassification Of Call Options
StockIssuedDuringPeriodValueEquitySettlementAndReclassificationOfCallOptions
-3100000 USD
CY2014Q2 vrx Stockholders Equity Before Comprehensive Income Net Of Tax
StockholdersEquityBeforeComprehensiveIncomeNetOfTax
5239200000 USD
CY2015Q2 vrx Stockholders Equity Before Comprehensive Income Net Of Tax
StockholdersEquityBeforeComprehensiveIncomeNetOfTax
6911500000 USD
CY2015Q2 vrx Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
359000000 USD
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform with the current year presentation.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div></div>
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is a multinational, specialty pharmaceutical and medical device company, continued under the laws of the Province of British Columbia, that develops, manufactures, and markets a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (&#8220;OTC&#8221;) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices), which are marketed directly or indirectly in over </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> countries. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 1, 2015, the Company acquired Salix Pharmaceuticals, Ltd. ("Salix"), pursuant to an Agreement and Plan of Merger dated February 20, 2015, as amended on March 16, 2015 (the "Merger Agreement"), with Salix surviving as a wholly owned subsidiary of Valeant Pharmaceuticals International ("Valeant"), a subsidiary of the Company (the "Salix Acquisition").</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For further information regarding the Salix Acquisition, including the related financing, see Note 3, Note 8 and Note 11.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing the unaudited consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the dates of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates and the operating results for the interim periods presented are not necessarily indicative of the results expected for the full&#160;year.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company&#8217;s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company&#8217;s results of operations and financial position could be materially impacted.</font></div></div>

Files In Submission

Name View Source Status
0000885590-15-000064-index-headers.html Edgar Link pending
0000885590-15-000064-index.html Edgar Link pending
0000885590-15-000064.txt Edgar Link pending
0000885590-15-000064-xbrl.zip Edgar Link pending
exhibit101.htm Edgar Link pending
exhibit102.htm Edgar Link pending
exhibit103.htm Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g63382g51k91.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
valeantq22015.htm Edgar Link pending
vrx-20150630.xml Edgar Link completed
vrx-20150630.xsd Edgar Link pending
vrx-20150630_cal.xml Edgar Link unprocessable
vrx-20150630_def.xml Edgar Link unprocessable
vrx-20150630_lab.xml Edgar Link unprocessable
vrx-20150630_pre.xml Edgar Link unprocessable